NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

CHE

Chemed Corp

Apr 25 • 04:00PM ET

555.74

Dollar change +8.96
Percentage change 1.64	%

Healthcare • Medical Care Facilities • USA • NYSE

Peers: ENSG EHC HCA SEM AMED HUM TDOC CYH ACHC UHS

| Held by: VTI IJH VB VXF VBK XMHQ MDY SDVY VIG SPMD

Scroll to Statements

Index	-	P/E	27.07	EPS (ttm)	20.53	Insider Own	1.86%	Shs Outstand	14.61M	Perf Week	-4.46%
Market Cap	8.12B	Forward P/E	20.29	EPS next Y	27.39	Insider Trans	-2.83%	Shs Float	14.34M	Perf Month	-8.77%
Income	308.74M	PEG	3.58	EPS next Q	5.99	Inst Own	95.62%	Short Float	1.67%	Perf Quarter	0.87%
Sales	2.49B	P/S	3.26	EPS this Y	8.99%	Inst Trans	-1.62%	Short Ratio	1.97	Perf Half Y	-6.37%
Book/sh	76.87	P/B	7.23	EPS next Y	8.63%	ROA	17.88%	Short Interest	0.24M	Perf Year	-9.86%
Cash/sh	11.90	P/C	46.71	EPS next 5Y	7.56%	ROE	26.11%	52W Range	512.12 - 623.60	Perf YTD	4.90%
Dividend Est.	2.05 (0.37%)	P/FCF	25.78	EPS past 5Y	8.37%	ROI	24.05%	52W High	-10.88%	Beta	0.61
Dividend TTM	1.90 (0.34%)	Quick Ratio	1.70	Sales past 5Y	4.68%	Gross Margin	32.28%	52W Low	8.52%	ATR (14)	17.71
Dividend Ex-Date	Feb 24, 2025	Current Ratio	1.73	EPS Y/Y TTM	10.36%	Oper. Margin	15.63%	RSI (14)	39.47	Volatility	3.65% 2.93%
Employees	15695	Debt/Eq	0.12	Sales Y/Y TTM	8.52%	Profit Margin	12.40%	Recom	1.50	Target Price	675.00
Option/Short	Yes / Yes	LT Debt/Eq	0.09	EPS Q/Q	14.66%	Payout	9.05%	Rel Volume	0.98	Prev Close	546.78
Sales Surprise	0.80%	EPS Surprise	1.50%	Sales Q/Q	9.79%	Earnings	Apr 23 AMC	Avg Volume	121.43K	Price	555.74
SMA20	-5.59%	SMA50	-5.19%	SMA200	-2.33%	Trades		Volume	118,857	Change	1.64%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-11-20	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$448 → $535
Nov-01-19	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform	$490
Sep-06-19	Reiterated	BofA/Merrill	Buy	$470 → $500
Oct-12-18	Initiated	BofA/Merrill	Buy	$390
Aug-28-17	Initiated	KeyBanc Capital Mkts	Sector Weight
Nov-01-16	Reiterated	RBC Capital Mkts	Sector Perform	$162 → $148
Jul-27-16	Reiterated	RBC Capital Mkts	Sector Perform	$136 → $162
May-02-16	Reiterated	RBC Capital Mkts	Sector Perform	$135 → $136
Oct-26-15	Reiterated	RBC Capital Mkts	Sector Perform	$129 → $154
Oct-26-15	Reiterated	Oppenheimer	Outperform	$150 → $152
Sep-22-15	Reiterated	Oppenheimer	Outperform	$147 → $150
Jul-27-15	Reiterated	RBC Capital Mkts	Sector Perform	$110 → $129
Feb-19-15	Reiterated	Oppenheimer	Outperform	$122 → $123
Sep-23-14	Reiterated	Oppenheimer	Outperform	$110 → $115
Jun-10-14	Reiterated	RBC Capital Mkts	Sector Perform	$70 → $74
May-01-14	Reiterated	Oppenheimer	Outperform	$90 → $92
Sep-10-13	Reiterated	Deutsche Bank	Hold	$70 → $63
Mar-04-11	Reiterated	Barclays Capital	Underweight	$65 → $9
Feb-17-11	Reiterated	RBC Capital Mkts	Sector Perform	$53 → $67
Feb-17-11	Reiterated	Oppenheimer	Outperform	$67 → $72

Show Previous Ratings

Apr-25-25 10:18AM	CHE Stock Falls Despite Q1 Earnings & Revenue Beat, Gross Margin Declines (Zacks)
12:11AM	Q1 2025 Chemed Corp Earnings Call (Thomson Reuters StreetEvents)
Apr-24-25 04:14PM	Chemed Corporation (CHE) Q1 2025 Earnings Call Transcript (Seeking Alpha) -6.61%
09:15AM	Chemed Corporation (CHE): A Bull Case Theory (Insider Monkey)
Apr-23-25 05:45PM	Chemed (CHE) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
05:02PM	Loading…
05:02PM	Chemed's (NYSE:CHE) Q1 Sales Beat Estimates (StockStory)
04:43PM	Chemed: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	Chemed Reports First-Quarter 2025 Results (Business Wire)
Apr-22-25 08:03AM	Chemed (CHE) Reports Earnings Tomorrow: What To Expect (StockStory)
Apr-15-25 05:01AM	Q4 Earnings Highs And Lows: Chemed (NYSE:CHE) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks (StockStory)
Apr-14-25 03:15PM	Aristotle Small/Mid Cap Equity Q1 2025 Commentary (Seeking Alpha)
11:40AM	OPCH or CHE: Which Is the Better Value Stock Right Now? (Zacks)
Apr-07-25 08:17AM	Chemed Corporation (CHE) Shares Retreated by -13% During TimesSquare U.S. FOCUS Growth Strategy's Holding Period (Insider Monkey)
Apr-03-25 05:05AM	Chemed (CHE): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
Apr-01-25 12:00PM	Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24 (Business Wire)
11:30AM	Loading…
Mar-28-25 11:30AM	Why Is Chemed (CHE) Up 4.5% Since Last Earnings Report? (Zacks)
Mar-20-25 11:40AM	OPCH vs. CHE: Which Stock Is the Better Value Option? (Zacks)
Mar-18-25 09:01AM	2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off (StockStory)
Mar-12-25 05:02AM	Senior Health, Home Health & Hospice Stocks Q4 Teardown: AdaptHealth (NASDAQ:AHCO) Vs The Rest (StockStory)
Mar-03-25 01:24PM	Chemed Corporation to Present at the Oppenheimer 35th Annual Healthcare Conference (Business Wire)
Feb-28-25 02:22AM	Chemed Corp (CHE) Q4 2024 Earnings Call Highlights: Strong VITAS Growth Amid Roto-Rooter Challenges (GuruFocus.com)
12:28AM	Q4 2024 Chemed Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-26-25 06:15PM	Chemed (CHE) Surpasses Q4 Earnings and Revenue Estimates (Zacks) +7.39%
05:15PM	Chemed: Q4 Earnings Snapshot (Associated Press Finance)
05:00PM	Chemeds (NYSE:CHE) Q4: Beats On Revenue (StockStory)
04:15PM	Chemed Reports Fourth-Quarter 2024 Results (Business Wire)
Feb-25-25 08:06AM	What To Expect From Chemeds (CHE) Q4 Earnings (StockStory)
Feb-14-25 01:30PM	Chemed Corporation Declares Quarterly Dividend of 50 Cents (Business Wire)
04:03AM	Winners And Losers Of Q3: AdaptHealth (NASDAQ:AHCO) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks (StockStory)
04:03AM	Senior Health, Home Health & Hospice Stocks Q3 Results: Benchmarking Brookdale (NYSE:BKD) (StockStory)
04:01AM	Loading…
04:01AM	Q3 Earnings Highs And Lows: Chemed (NYSE:CHE) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks (StockStory)
Feb-13-25 01:13PM	Senior Health, Home Health & Hospice Stocks Q3 Teardown: The Pennant Group (NASDAQ:PNTG) Vs The Rest (StockStory)
04:01AM	Senior Health, Home Health & Hospice Stocks Q3 Earnings Review: Option Care Health (NASDAQ:OPCH) Shines (StockStory)
Feb-11-25 05:35PM	Chemed To Report Fourth-Quarter 2024 Earnings February 26, Related Conference Call To Be Held On February 27 (Business Wire)
04:03AM	Senior Health, Home Health & Hospice Stocks Q3 Teardown: BrightSpring Health Services (NASDAQ:BTSG) Vs The Rest (StockStory)
04:02AM	Q3 Earnings Highlights: Addus HomeCare (NASDAQ:ADUS) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks (StockStory)
Jan-07-25 12:00PM	Chemed Corporation to Present at the 43rd Annual JPMorgan Healthcare Conference (Business Wire)
Dec-03-24 12:00PM	Chemed Corporation to Present at the BofA Securities 2024 Virtual Home Care Conference (Business Wire)
Nov-28-24 08:28AM	Heres Why Chemed Corporation (CHE) Rose in Q3 (Insider Monkey)
Nov-08-24 11:43AM	Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 50 Cents (Business Wire)
Nov-05-24 12:00PM	Chemed Corporation to Present at the UBS 2024 Global Healthcare Conference (Business Wire)
Oct-31-24 03:10AM	Chemed Corp (CHE) Q3 2024 Earnings Call Highlights: VITAS Shines Amid Roto-Rooter's Challenges (GuruFocus.com)
01:54AM	Q3 2024 Chemed Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-29-24 05:55PM	Chemed (CHE) Lags Q3 Earnings and Revenue Estimates (Zacks) -12.14%
04:52PM	Chemed: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Chemed Reports Third-Quarter 2024 Results (Business Wire)
Oct-01-24 01:37PM	Final Trades: Exxon, Chemed, Las Vegas Sands and the IEO (CNBC TV)
Sep-18-24 09:45AM	Why Chemed (CHE) is a Top Growth Stock for the Long-Term (Zacks)
Sep-13-24 01:46PM	Chemed To Report Third-Quarter 2024 Earnings October 29, Related Conference Call To Be Held On October 30 (Business Wire)
Sep-11-24 09:44AM	Heres Why Chemed Corporation (CHE) Declined in Q2 (Insider Monkey)
Sep-10-24 03:00PM	Insider Sale: Executive Vice President Nicholas Westfall Sells Shares of Chemed Corp (CHE) (GuruFocus.com)
Aug-23-24 11:30AM	Chemed (CHE) Up 5.7% Since Last Earnings Report: Can It Continue? (Zacks)
Aug-15-24 09:45AM	Here's Why Chemed (CHE) is a Strong Growth Stock (Zacks)
Aug-09-24 05:00PM	Insider Sale: Vice President Thomas Hutton Sells Shares of Chemed Corp (CHE) (GuruFocus.com)
05:00PM	Insider Sale: Executive Vice President Spencer Lee Sells Shares of Chemed Corp (CHE) (GuruFocus.com)
Aug-08-24 11:17AM	3 Ways to Play the Long-Term Care Crisis in 2024 (InvestorPlace)
Aug-07-24 01:45PM	Trade Tracker: Karen Firestone buys Abbott Labs, Chemed, Costar Group and sells Home Depot (CNBC TV)
Aug-02-24 11:54AM	Chemed Corporation Declares Quarterly Dividend of 50 Cents (Business Wire)
Jul-31-24 01:00PM	Insider Sale: Executive Vice President Nicholas Westfall Sells Shares of Chemed Corp (CHE) (GuruFocus.com)
Jul-30-24 09:45AM	Why Chemed (CHE) is a Top Growth Stock for the Long-Term (Zacks)
Jul-29-24 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Chemed (CHE) (Zacks)
Jul-26-24 03:11AM	Q2 2024 Chemed Corp Earnings Call (Thomson Reuters StreetEvents)
Jul-25-24 08:49AM	Chemed (CHE) Q2 Earnings Miss Estimates, Margins Expand (Zacks)
Jul-24-24 06:05PM	Chemed (CHE) Misses Q2 Earnings and Revenue Estimates (Zacks)
05:04PM	Chemed: Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	Chemed Reports Second-Quarter 2024 Results (Business Wire)
Jul-16-24 09:10AM	Should You Keep Chemed (CHE) Stock in Your Portfolio Now? (Zacks)
Jul-01-24 12:00PM	Chemed To Report Second-Quarter 2024 Earnings July 24, Related Conference Call To Be Held On July 25 (Business Wire)
Jun-13-24 07:01PM	Insider Selling: Director Patrick Grace Sells Shares of Chemed Corp (CHE) (GuruFocus.com)
Jun-08-24 02:58AM	Insider Sale: President and CEO Kevin Mcnamara Sells Shares of Chemed Corp (CHE) (GuruFocus.com)
May-29-24 12:00PM	Chemed Corporation to Present at the Jefferies 2024 Global Healthcare Conference (Business Wire)
May-24-24 11:31AM	Chemed (CHE) Down 3.1% Since Last Earnings Report: Can It Rebound? (Zacks)
May-20-24 02:49PM	Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend (Business Wire)
May-17-24 03:00PM	Chemed Corp (CHE) CEO Kevin Mcnamara Sells 4,000 Shares (GuruFocus.com)
11:15AM	Chemed Insider Sold Shares Worth $2,270,160, According to a Recent SEC Filing (MT Newswires)
May-07-24 12:00PM	Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2024 (Business Wire)
Apr-30-24 12:15PM	Chemed Corporation (NYSE:CHE) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-26-24 12:35PM	Chemed Reports 'Soft' Q1 as Roto-Rooter Continues to Face Pressure, Oppenheimer Says (MT Newswires)
03:17AM	Chemed Corp (CHE) Q1 2024 Earnings Call Transcript Highlights: Diverse Performance Across ... (GuruFocus.com)
Apr-25-24 11:37PM	Q1 2024 Chemed Corp Earnings Call (Thomson Reuters StreetEvents) -7.22%
08:27AM	Chemed (CHE) Lags Q1 Earnings Estimates, Reaffirms 2024 View (Zacks)
Apr-24-24 06:10PM	Chemed (CHE) Q1 Earnings Miss Estimates (Zacks)
05:35PM	Chemed Corp (CHE) Q1 2024 Earnings: Mixed Results Amidst Segment Variances (GuruFocus.com)
05:14PM	Chemed Q1 Adjusted Earnings, Revenue Rise -- Shares Down After Hours (MT Newswires)
05:05PM	Chemed: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	Chemed Reports First-Quarter 2024 Results (Business Wire)
Apr-17-24 10:26AM	Here's Why You Should Retain Chemed (CHE) Stock for Now (Zacks)
10:00AM	VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama (Business Wire)
Apr-03-24 04:29AM	Chemed Corporation (CHE) Rose 13% in Q4 (Insider Monkey)
Apr-01-24 03:00PM	Chemed Corp Executive Vice President Spencer Lee Sells Company Shares (GuruFocus.com)
12:00PM	Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25 (Business Wire)
Mar-28-24 11:30AM	Chemed (CHE) Up 2.5% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-22-24 03:00PM	Chemed Corp VP and Chief Legal Officer Brian Judkins Sells 11,158 Shares (GuruFocus.com)
Mar-18-24 09:45AM	Chemed (CHE) Reaches a New 52-Week High: What's Driving It? (Zacks)
Mar-14-24 09:00AM	Chemed's (CHE) VITAS Segment Inks New Deal With Covenant Care (Zacks)
Mar-13-24 09:00AM	VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama (Business Wire)
Mar-08-24 12:00PM	Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference (Business Wire)
Mar-04-24 12:45PM	Is Chemed (CHE) a Solid Growth Stock? 3 Reasons to Think 'Yes' (Zacks)
Feb-29-24 09:03AM	Chemed Corporation (NYSE:CHE) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:37AM	Chemed (CHE) Q4 Earnings Surpass Estimates, Margins Expand (Zacks)

Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MCNAMARA KEVIN J	president and CEO	Mar 31 '25	Sale	615.33	1,000	615,330	101,679	Apr 01 11:05 AM
MCNAMARA KEVIN J	Director	Mar 31 '25	Proposed Sale	605.70	1,000	605,700		Mar 31 03:54 PM
Witzeman Michael D	VP & Chief Financial Officer	Mar 10 '25	Option Exercise	445.35	8,796	3,917,299	13,154	Mar 11 03:12 PM
MCNAMARA KEVIN J	president and CEO	Mar 06 '25	Sale	593.67	2,000	1,187,340	102,679	Mar 07 11:03 AM
MCNAMARA KEVIN J	Director	Mar 06 '25	Proposed Sale	593.60	2,000	1,187,199		Mar 06 04:28 PM
LEE SPENCER S	executive vice president	Mar 03 '25	Sale	592.25	1,326	785,324	17,627	Mar 03 03:28 PM
LEE SPENCER S	executive vice president	Feb 14 '25	Option Exercise	553.39	1,073	593,787	19,295	Feb 18 05:22 PM
Westfall Nicholas Michael	Executive Vice President	Feb 14 '25	Option Exercise	553.39	1,473	815,143	7,582	Feb 18 05:05 PM
Witzeman Michael D	VP & Chief Financial Officer	Feb 14 '25	Option Exercise	553.39	850	470,382	4,634	Feb 18 04:49 PM
HUTTON THOMAS C	vice president	Feb 14 '25	Option Exercise	553.39	411	227,443	33,176	Feb 18 04:03 PM
MCNAMARA KEVIN J	president and CEO	Feb 14 '25	Option Exercise	553.39	5,321	2,944,588	107,056	Feb 18 03:41 PM
Judkins Brian C	VP and Chief Legal Officer	Feb 14 '25	Option Exercise	553.39	724	400,654	2,402	Feb 18 03:14 PM
Judkins Brian C	VP and Chief Legal Officer	Dec 30 '24	Buy	519.50	145	75,328	1,678	Dec 30 11:10 AM
LEE SPENCER S	executive vice president	Nov 27 '24	Sale	575.62	732	421,356	18,287	Nov 29 10:38 AM
MCNAMARA KEVIN J	president and CEO	Nov 25 '24	Sale	572.77	2,000	1,145,540	101,735	Nov 26 11:24 AM
MCNAMARA KEVIN J	Officer	Nov 25 '24	Proposed Sale	571.11	2,000	1,142,220		Nov 25 03:44 PM
LEE SPENCER S	executive vice president	Nov 22 '24	Sale	565.71	1,000	565,710	19,019	Nov 22 01:37 PM
MCNAMARA KEVIN J	president and CEO	Sep 26 '24	Sale	598.81	2,000	1,197,620	103,735	Sep 27 11:27 AM
WALSH GEORGE J III	Director	Sep 26 '24	Sale	597.47	400	238,988	3,046	Sep 27 11:17 AM
MCNAMARA KEVIN J	Director	Sep 26 '24	Proposed Sale	598.75	2,000	1,197,505		Sep 26 04:22 PM
Westfall Nicholas Michael	Executive Vice President	Sep 09 '24	Sale	569.35	1,713	975,297	6,109	Sep 10 11:14 AM
Westfall Nicholas Michael	Executive Vice President	Sep 04 '24	Option Exercise	471.74	15,333	7,233,189	21,442	Sep 06 10:20 AM
LINDELL ANDREA R	Director	Aug 16 '24	Sale	571.51	831	474,925	5,725	Aug 26 12:21 PM
WALSH GEORGE J III	Director	Aug 21 '24	Sale	577.95	200	115,590	3,446	Aug 22 12:06 PM
LEE SPENCER S	executive vice president	Aug 09 '24	Option Exercise	413.19	9,000	3,718,710	27,611	Aug 09 02:13 PM
LEE SPENCER S	executive vice president	Aug 08 '24	Sale	580.48	1,016	589,768	18,611	Aug 09 02:13 PM
HUTTON THOMAS C	vice president	Aug 06 '24	Sale	576.32	4,827	2,781,897	32,765	Aug 09 01:56 PM
MCNAMARA KEVIN J	Director	Aug 05 '24	Proposed Sale	569.57	2,000	1,139,142		Aug 06 11:17 AM
MCNAMARA KEVIN J	president and CEO	Aug 05 '24	Option Exercise	445.35	5,000	2,226,750	112,049	Aug 06 11:14 AM
MCNAMARA KEVIN J	president and CEO	Aug 05 '24	Sale	569.63	2,000	1,139,260	105,735	Aug 06 11:14 AM
HUTTON THOMAS C	Director	Aug 01 '24	Proposed Sale	554.39	4,827	2,676,041		Aug 01 04:07 PM
Witzeman Michael D	VP & Chief Financial Officer	Jul 31 '24	Option Exercise	471.74	7,948	3,749,390	11,009	Aug 01 03:42 PM
Westfall Nicholas Michael	Executive Vice President	Jul 30 '24	Sale	561.58	2,000	1,123,160	5,990	Jul 31 10:49 AM
Nicholas M. Westfall	Officer	Jul 30 '24	Proposed Sale	550.29	23,000	12,656,670		Jul 30 11:36 AM
GRACE PATRICK P	Director	Jun 12 '24	Sale	540.98	284	153,638	3,270	Jun 13 03:45 PM
MCNAMARA KEVIN J	president and CEO	Jun 06 '24	Sale	544.17	1,500	816,255	107,049	Jun 07 03:11 PM
MCNAMARA KEVIN J	president and CEO	May 16 '24	Sale	567.54	4,000	2,270,160	108,549	May 17 11:05 AM
Witzeman Michael D	VP & Chief Financial Officer	May 07 '24	Option Exercise	413.19	1,100	454,509	3,982	May 09 01:34 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CHE

Chemed Corp

Upgrade your FINVIZ experience